The Effectiveness of self-care package on glycemic control and self efficacy in pregnant diabetic Wome

Phase 2

• Conditions: Pregnancy Diabetes.; Pre-existing diabetes mellitus, insulin-dependent, Pre-existing diabetes mellitus, non-insulin-dependent, Diabetes mellitus arising in pregnancy; O24.0, O24

• Registration Number: IRCT2015102824753N1
• Lead Sponsor: Vice chancellor for research, Kermanshah University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 280

Inclusion Criteria

being pregnant; having diabetes (gestational or overt) confirmed by reliable tests according to the Health Ministry guideline; being able to read and write in Persian; being able to answer the questionnaire independently and sign the consent letter; having no visual or hearing impairment or mental illnesses which needs medication or psychiatrist continuous care; and having no previous experience of participation in any diabetes self care training programs; not being addicted to alcohol; cigarette or drugs; gestational diabetes has been diagnosed not more than a month; gestational age should not be more than 28 weeks; the patient should not experience any intensive stressful events during the study.
Exclusion criteria: refusing from cooperation in the study; being absent for two or more educational sessions; occurrence of high-risk pregnancy complications such as vaginal bleeding; preeclampsia; preterm labor; admission in hospital due to any reason; multiple pregnancy; the patient should not be a member of medical and paramedical staff.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Self-efficacy. Timepoint: baseline (pre-intervention) and one month after intervention. Method of measurement: by use of self-efficacy questionare of Stanford University.;Blood sugar. Timepoint: baseline (pre-intervention) and one month after intervention. Method of measurement: level of fast blood sugar,and 2 hour post prandial.

Secondary Outcome Measures

Name	Time	Method
Maternal and neonatal results. Timepoint: in and after delivery. Method of measurement: Determining Apgar score, neonatal birth weight, method of delivery and neonatal admission.